Fig. 9From: The effect of a novel glycolysis-related gene signature on progression, prognosis and immune microenvironment of renal cell carcinomaThe assessments of invasive abilities of CD44, PLOD1 and PLOD2 through Transwell assays. a-c Knockdown of CD44, PLOD1 and PLOD2 can inhibit the invasion of A498 cells. d-f Knockdown of CD44, PLOD1 and PLOD2 can inhibit the invasion of 789-O cells. NC, negative controlBack to article page